Safety and Pharmacokinetics of the Substance of the Anti-Smallpox Drug NIOCH-14 after Oral Administration to Laboratory Animals

Background: Since most of the modern human population has no anti-smallpox immunity, it is extremely important to develop and implement effective drugs for the treatment of smallpox and other orthopoxvirus infections. The objective of this study is to determine the main characteristics of the chemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shishkina, Larisa N., Mazurkov, Oleg Yu., Bormotov, Nikolai I., Skarnovich, Maksim O., Serova, Olga A., Mazurkova, Natalia A., Skarnovich, Maria A., Chernonosov, Alexander A., Selivanov, Boris A., Tikhonov, Alexey Ya., Gamaley, Svetlana G., Shimina, Galina G., Sysoyeva, Galina M., Taranov, Oleg S., Danilenko, Elena D., Agafonov, Alexander P., Maksyutov, Rinat A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863109/
https://www.ncbi.nlm.nih.gov/pubmed/36680245
http://dx.doi.org/10.3390/v15010205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863109/
https://www.ncbi.nlm.nih.gov/pubmed/36680245
http://dx.doi.org/10.3390/v15010205

Ejemplares similares